ADAMTS15 and prostate carcinoma: LNCaP represent a less malignant stage of prostate cancer than PC-3 cells, with reduced levels of both proliferation and migration as well as lower VCAN expression (data not shown), which might explain why tumor-suppressor functions for ADAMTS-15 were less readily observed in this cell line.